Together, results demonstrated that hsa_circ_0041268 acted as tumor promoter through novel hsa_circ_0041268/miR-214-5p/ROCK1 axis, which highlighted its potential as NSCLC therapeutic agent.
Hsa_circ_0041268 promotes NSCLC progress by sponging miR-214-5p/ROCK1.